Identification and construction of combinatory cancer hallmark–based gene signature sets to predict recurrence and chemotherapy benefit in stage II colorectal cancer

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1001/jamaoncol.2015.3413
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: ; Search for: 2 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
  2. National Research Council Canada
FormatText
TypeArticle
Journal titleJAMA Oncology
ISSN2374-2437
Volume2
Issue1
Pages3745
Abstract
Publication date
PublisherAmerican Medical Association
LanguageEnglish
Peer reviewedYes
NPARC number23000283
Export citationExport as RIS
Report a correctionReport a correction
Record identifiere8223e68-3797-4ba5-9952-6894d04b7fa6
Record created2016-07-04
Record modified2016-07-04
Date modified: